GIORGETTI, GIULIA
 Distribuzione geografica
Continente #
EU - Europa 380
AS - Asia 176
NA - Nord America 126
Continente sconosciuto - Info sul continente non disponibili 16
SA - Sud America 11
AF - Africa 3
Totale 712
Nazione #
IT - Italia 361
US - Stati Uniti d'America 115
BD - Bangladesh 55
SG - Singapore 53
CN - Cina 28
VN - Vietnam 27
CA - Canada 7
BR - Brasile 6
HK - Hong Kong 6
DE - Germania 5
FR - Francia 4
AR - Argentina 3
FI - Finlandia 2
GB - Regno Unito 2
ID - Indonesia 2
UA - Ucraina 2
AT - Austria 1
BB - Barbados 1
BO - Bolivia 1
EC - Ecuador 1
EG - Egitto 1
GT - Guatemala 1
HN - Honduras 1
IN - India 1
IQ - Iraq 1
JP - Giappone 1
LB - Libano 1
LT - Lituania 1
MG - Madagascar 1
MX - Messico 1
NL - Olanda 1
RO - Romania 1
TR - Turchia 1
ZA - Sudafrica 1
Totale 696
Città #
Genoa 303
Singapore 30
San Jose 20
Ho Chi Minh City 14
Vado Ligure 14
Ashburn 11
Council Bluffs 8
Beijing 6
Hong Kong 6
Rapallo 6
Los Angeles 5
New York 5
Buffalo 4
Frankfurt am Main 4
Santa Clara 4
Hanoi 3
Lauterbourg 3
Milan 3
Parma 3
Rome 3
Shenzhen 3
Boardman 2
Endicott 2
Haiphong 2
Helsinki 2
Palermo 2
Phoenix 2
Westminster 2
Whitefield 2
Albignasego 1
Amsterdam 1
Antakya 1
Antananarivo 1
Bergenfield 1
Biên Hòa 1
Brantford 1
Bridgetown 1
Brooklyn 1
Buenos Aires 1
Cairo 1
Chicago 1
Cuenca 1
Dallas 1
Depok 1
Des Moines 1
Durban 1
Florence 1
Formosa 1
Fort Lauderdale 1
Glace Bay 1
Grand Prairie 1
Guatemala City 1
Houston 1
Hải Dương 1
Indianapolis 1
Jamestown 1
Janesville 1
Karbala 1
Kyiv 1
La Paz 1
London 1
Massarosa 1
Miami 1
Middletown 1
Mumbai 1
New Orleans 1
Nuremberg 1
Ontario 1
Orem 1
Osasco 1
Ottawa 1
Paulista 1
Pimenta Bueno 1
Pittsburgh 1
Plainfield 1
Ploieşti 1
Ponte dell'Olio 1
Poplar 1
Prato 1
Pulversheim 1
Quảng Nam Province 1
Salt Lake City 1
Saquarema 1
Sassuolo 1
Schenectady 1
Schiavon 1
Sidon 1
São Paulo 1
Thái Nguyên 1
Tokyo 1
Toronto 1
Tres de Febrero 1
Turin 1
Ubá 1
Valdosta 1
Vancouver 1
Venice 1
Whitby 1
Yoakum 1
Zhytomyr 1
Totale 545
Nome #
CD38-Induced Metabolic Dysfunction Primes Multiple Myeloma Cells for NAD+-Lowering Agents 176
NAD+ METABOLISM RESTRICTION BOOSTS HIGH-DOSE MELPHALAN EFFICACY IN PATIENTS WITH MULTIPLE MYELOMA 176
CD56-OVEREXPRESSING MYELOMA CELLS ARE MORE VULNERABLE TO NAD+ EXHAUSTING STRATEGIES DUE TO DEPENDENCY ON CD38 ENZYMATIC ACTIVITY 112
Higher CD56 Expression on Multiple Myeloma Cells Increases CD38 Expression, Reduces Intracellular NAD+ Levels, and Enhances the Efficacy of Daratumumab-Based Treatment Strategies 67
The NAD + Metabolic Dependency Restriction Overcomes Drug-Resistance Phenotype of Multiple Myeloma CELLS 52
A Novel Ribonuclease Targeting Small Molecule RNA-Degrader (MYC-RiboTAC) Overcomes MYC Dependency in Multiple Myeloma 42
Venetoclax resistance leads to broad resistance to standard-of-care anti-MM agents, but not to immunotherapies 39
PKMYT1 Kinase Is an Actionable Synthetically Lethal Target for Del17p Myeloma 24
Partial Inhibition Of Nampt Restores Metabolic Vulnerability And Synergizes With Anti-Myeloma Agents In Multiple Myeloma 24
Totale 712
Categoria #
all - tutte 1.856
article - articoli 1.132
book - libri 0
conference - conferenze 527
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.515


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202310 0 0 0 0 0 0 0 2 0 3 3 2
2023/202432 1 3 7 7 4 2 1 4 1 0 0 2
2024/2025139 3 3 3 3 3 12 6 16 6 22 25 37
2025/2026487 45 18 48 54 47 22 33 27 33 33 74 53
2026/202744 44 0 0 0 0 0 0 0 0 0 0 0
Totale 712